James Citty, MD
Obstetrics & Gynecology · Searcy, ARNPI 1316141963
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.6% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $520 and has fallen 61.6% since, to $199 in 2025.
Across 79 payments — averaging $22.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mayne Pharma Commercial LLC$216
- GSK$207
- Davol Inc.$199
- AbbVie$163
- Intuitive Surgical$137
- Exeltis, USA Inc.$130
- plus $689 from 17 others
Across 82 payments — averaging $1899.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$156K
What the payments were for
- Food & beverage$1,64695%
- Education$945%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mayne Pharma Commercial LLC | 14 | $216 |
| GSK | 14 | $207 |
| Davol Inc. | 6 | $199 |
| AbbVie | 8 | $163 |
| Intuitive Surgical | 2 | $137 |
| Exeltis, USA Inc. | 5 | $130 |
| Astellas Pharma US Inc | 2 | $115 |
| Minerva Surgical, Inc | 2 | $89 |
| Amgen | 4 | $72 |
| Conmed Corporation | 2 | $58 |
| Pfizer | 4 | $58 |
| Organon | 2 | $47 |
| Organogenesis Inc. | 1 | $36 |
| Bayer | 2 | $35 |
| Medtronic | 2 | $32 |
| Therapeuticsmd, Inc. | 1 | $31 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Kinex Medical Company LLC | 1 | $4 |
How this compares
$1,740 in reported general payments places this provider in the 55th percentile of 272 obstetrics & gynecology providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 89 | $2,854 |
| Medroxyprogesterone Acetate | 25 | $262 |
| Norethindrone Acetate | 12 | $241 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Searcy
- Michael CopeLittle Rock$147K
- Jeanmarie HouseholderFort Smith$140K
- Timothy BellFort Smith$53K
- Paige PartridgeJohnson$50K
- David ShenkerLittle Rock$28K
- Christopher TaylorHarrison$24K
- Julia GoodwinLittle Rock$16K
- Lisa WatermanSpringdale$16K
- Erin LargeFayetteville$16K
- Christopher HallRogers$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.